Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 3666 participants.

Also called NCT07121088

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 3,666 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07121088
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07121088. Non-randomized; no masking; primary purpose treatment. Start 2025-08-31 (anticipated); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study
Acronym
TIDES
Condition
Ischemic Cerebral Infarction
Condition
Diabetes Mellitus
Intervention (Drug)
(Intensive treatment) Chuanzhi Tongluo Capsules
Intervention (Other)
Standard Treatment (Guideline-Based)
Intervention (Drug)
(Sequential treatment) Chuanzhi Tongluo Capsules
Intervention (Drug)
TCM Syndrome Differentiation Decoction
Lead sponsor
Guangzhou University of Traditional Chinese Medicine (class: other)

Record details

Record id
cardio:ct-nct07121088
Content hash
6f0b88e50b85dfbc61a8c9ded5cb3ce57d653aa2a2f8862c2c1181a7f73c7afd